

Caladrius Biosciences, Inc., through its subsidiary, PCT, is a leading development and manufacturing partner to the cell therapy industry. Among its major competitors, Caladrius Biosciences is ranked in 11th place for NPS while GlaxoSmithKline is 1st, and Genentech is 2nd.